Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA

Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00866918	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia	completed	Phase 3	106	Children's Oncology GroupNETWORK	3	Oct 25, 2022	clinicaltrials
NCT01445080	Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia	completed	Phase 1 / Phase 2	70	National Cancer Institute (NCI)NIH	2	Feb 2, 2021	clinicaltrials